Table 1. Participant characteristics stratified by statin use at baseline.

Variable	Statin Use		p Value*
	No (n = 337)	Yes (n = 242)
Age (years)	73.0 ± 8.9	72.1 ± 7.9	0.21
Men	56.3%	59.5%	0.44
Black race	18.1%	12.0%	0.045
Ankle brachial index	0.64 ± 0.15	0.65 ± 0.15	0.91
Body mass index (kg/m2)	27.2 ± 5.3	28.2 ± 4.8	0.02
Cigarette smoking (pack years)	37.0 ± 36.7	37.6 ± 34.5	0.86
Total cholesterol (mg/dl)	185.3 ± 40.4	169.8 ± 35.7	<0.001
High-density lipoprotein cholesterol (mg/dl)	45.3 ± 19.1	43.6 ± 15.4	0.27
Blocks walked during past week	36.9 ± 69.1	29.9 ± 52.7	0.18
Diabetes mellitus	34.1%	31.4%	0.49
Pulmonary disease	38.0%	34.7%	0.42
Cancer	17.8%	18.6%	0.81
Hypertension (by history)	88.0%	91.2%	0.23
Cardiac or cerebrovascular disease†	47.8%	64.0%	<0.001
Baseline C-reactive protein level (mg/L)	6.1 ± 10.5	3.8 ± 4.0	0.002
Baseline D-dimer level‡ (μg/ml)	1.1 ± 1.4	0.97 ± 1.4	0.50

Data are presented as mean ± SD or %, unless otherwise noted.

^*Derived from comparisons between statin users and statin nonusers.

^†Cardiac or cerebrovascular disease was defined as ≥ 1 of the following: history of myocardial infarction, heart failure, angina, and stroke.

^‡Data are presented as mean ± SD.